Style | Citing Format |
---|---|
MLA | Asgari S, et al.. "Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases." Iranian Journal of Diabetes and Lipid Disorders, vol. 4, no. 2, 2005, pp. E3+E3i-E3vii. |
APA | Asgari S, Gharipour M, Naderi G, Sabet B, Khosravi A, Hashemi M (2005). Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases. Iranian Journal of Diabetes and Lipid Disorders, 4(2), E3+E3i-E3vii. |
Chicago | Asgari S, Gharipour M, Naderi G, Sabet B, Khosravi A, Hashemi M. "Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases." Iranian Journal of Diabetes and Lipid Disorders 4, no. 2 (2005): E3+E3i-E3vii. |
Harvard | Asgari S et al. (2005) 'Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases', Iranian Journal of Diabetes and Lipid Disorders, 4(2), pp. E3+E3i-E3vii. |
Vancouver | Asgari S, Gharipour M, Naderi G, Sabet B, Khosravi A, Hashemi M. Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases. Iranian Journal of Diabetes and Lipid Disorders. 2005;4(2):E3+E3i-E3vii. |
BibTex | @article{ author = {Asgari S and Gharipour M and Naderi G and Sabet B and Khosravi A and Hashemi M}, title = {Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases}, journal = {Iranian Journal of Diabetes and Lipid Disorders}, volume = {4}, number = {2}, pages = {E3+E3i-E3vii}, year = {2005} } |
RIS | TY - JOUR AU - Asgari S AU - Gharipour M AU - Naderi G AU - Sabet B AU - Khosravi A AU - Hashemi M TI - Evaluation of Autoantibody Against Modified Ldl Levels in Patients With Cardiovascular Diseases JO - Iranian Journal of Diabetes and Lipid Disorders VL - 4 IS - 2 SP - E3+E3i EP - E3vii PY - 2005 ER - |